Chemoinformaics analysis of 2,3-butanedione
| Molecular Weight | 86.09 | nRot | 1 |
| Heavy Atom Molecular Weight | 80.042 | nRig | 2 |
| Exact Molecular Weight | 86.0368 | nRing | 0 |
| Solubility: LogS | 0.635 | nHRing | 0 |
| Solubility: LogP | -0.161 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 12 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 6 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 6 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 4 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 12.2848 |
| nHD | 0 | BPOL | 7.75524 |
| QED | 0.426 |
| Synth | 1.916 |
| Natural Product Likeliness | 0.107 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.001 |
| HIA | 0.008 |
| CACO-2 | -4.344 |
| MDCK | 0.000045 |
| BBB | 0.926 |
| PPB | 0.44946 |
| VDSS | 0.385 |
| FU | 0.622658 |
| CYP1A2-inh | 0.412 |
| CYP1A2-sub | 0.778 |
| CYP2c19-inh | 0.082 |
| CYP2c19-sub | 0.511 |
| CYP2c9-inh | 0.011 |
| CYP2c9-sub | 0.551 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.289 |
| CYP3a4-inh | 0.005 |
| CYP3a4-sub | 0.297 |
| CL | 6.003 |
| T12 | 0.817 |
| hERG | 0.027 |
| Ames | 0.476 |
| ROA | 0.066 |
| SkinSen | 0.871 |
| Carcinogencity | 0.032 |
| EI | 0.989 |
| Respiratory | 0.653 |
| NR-Aromatase | 0.007 |
| Antiviral | No |
| Prediction | 0.984427 |